 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 02/15/2019 |
$81.13 |
$81.70 |
$80.16 |
$80.85 |
6.30M | | 02/19/2019 |
$80.50 |
$81.52 |
$80.23 |
$80.52 |
5.67M | | 02/20/2019 |
$80.53 |
$80.60 |
$79.14 |
$79.99 |
5.56M | | 02/21/2019 |
$79.74 |
$79.91 |
$78.10 |
$78.75 |
6.36M | | 02/22/2019 |
$79.16 |
$80.19 |
$78.24 |
$80.02 |
5.02M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co.'s portfolio of products includes a line of therapies that addresses serious diseases such as: HUMIRA (adalimumab) to treat autoimmune diseases; oncology products such as IMBRUVICA (ibrutinib) and Venclexta (venetoclax); virology products such as VIEKIRA PAK for the treatment of hepatitis C and Norvir (ritonavir) for the treatment of human immunodeficiency virus-1 infection; metabolic and hormone products that target conditions such as testosterone deficiency; endocrinology products such as Lupron (leuprolide acetate) for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty. | |
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on February 15, 2019, ABBV opened at $81.13, traded as high as $81.70 and as low as $80.16, and closed at $80.85. Trading volume was a total of 6.30M shares. On February 19, 2019, ABBV opened at $80.50, traded as high as $81.52 and as low as $80.23, and closed at $80.52. Trading volume was a total of 5.67M shares. On February 20, 2019, ABBV opened at $80.53, traded as high as $80.60 and as low as $79.14, and closed at $79.99. Trading volume was a total of 5.56M shares. On February 21, 2019, ABBV opened at $79.74, traded as high as $79.91 and as low as $78.10, and closed at $78.75. Trading volume was a total of 6.36M shares. On February 22, 2019, ABBV opened at $79.16, traded as high as $80.19 and as low as $78.24, and closed at $80.02. Trading volume was a total of 5.02M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
02/22/2019 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$80.02 |
|
| Starting shares: |
284.74 |
|
| Ending shares: |
358.08 |
|
| Dividends reinvested/share: |
$14.78 |
|
| Total return: |
186.53% |
|
| Average Annual Total Return: |
18.69% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$28,647.47 |
|
| Years: |
6.14 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
02/22/2019 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$80.02 |
|
| Dividends collected/share: |
$14.78 |
|
| Total return: |
169.93% |
|
| Average Annual Total Return: |
17.55% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$26,998.53 |
|
| Years: |
6.14 |
|
|
|
| Date |
Close |
| 02/15/2019 | $80.85 | | 02/19/2019 | $80.52 | | 02/20/2019 | $79.99 | | 02/21/2019 | $78.75 | | 02/22/2019 | $80.02 |
|
|
